AHSG was additionally proposed as a potential biomarker for the differential diagnosis of ischemic cardiomyopathy from dilated cardiomyopathy, where low levels of AHSG were observed in patients with ischemic cardiomyopathy [46]. The gene discussed is AHSG; the disease is dilated cardiomyopathy.